DS
LKFT

David Shaw’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

David Shaw’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,200
Closed -$507K – 5674
2021
Q4 		$507K Hold
9,200
– – ﹤0.01% 4394
2021
Q3 		$484K Hold
9,200
– – ﹤0.01% 4099
2021
Q2 		$634K Buy
+9,200
New +$702K ﹤0.01% 3900

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

David Shaw's LKFT Position: Q2 2026 in Review

David Shaw reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 8.3% in Q2 2026, selling an estimated $507K and leaving 197,844 shares worth $5.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

David Shaw first reported a position in LKFT in Q3 2018 and has held it in 27 quarters since. The position peaked at $8.99M in Q4 2025. 77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • David Shaw held 197,844 shares of Lakefront Biotherapeutics American Depositary Shares worth $5.93M as of Q2 2026.
  • David Shaw sold 17,874 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $507K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2263 holding.
  • David Shaw first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 27 quarters since.
  • David Shaw's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.99M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.